Literature DB >> 9415851

Factors influencing the diagnostic accuracy of dobutamine stress echocardiography.

K Schröder1, R Agrawal, H Völler, B Kürsten, R Dissmann, H P Schultheiss.   

Abstract

BACKGROUND: While Dobutamine stress echocardiography is a well established tool, the range of the diagnostic accuracy found in the literature is rather large. The main reason for this is the fact, that different test protocols were used. Aim of this study was to assess the effects of both addition of atropine as well as consideration of a hyperdynamic response while interpreting the stress echocardiogram on the diagnostic accuracy. METHODS AND
RESULTS: 120 consecutive patients were examined and divided into the following groups: A) achieving their age predicted heart rate with dobutamine, B) termination of the test due to ischemia, C1) negative test without reaching the predicted heart rate, and C2) C1 following addition of atropine. All of the echocardiograms were analyzed twice: 1) regarding the lack of a hyperdynamic response to dobutamine as ischemia (Hyper analysis), and 2) ignoring the hypercontractility (Conventional analysis). The accuracy of A and B were 88% and 90% resp. Group C1 had a very poor accuracy of 60%. This rose significantly (p < 0.01) after atropine (C2 = 84%), without leading to an increase of adverse effects. Conventional wallmotion analysis lead to an overall accuracy of 87% (groups A, B, and C2), while Hyper analysis showed an accuracy of 90% (p < 0.01).
CONCLUSIONS: To achieve a high accuracy Dobutamine stress echocardiography should always be combined with atropine to reach a target heart rate. The wallmotion analysis should be based on the assumption that a hyperdynamic response to dobutamine is normal, while its lack is indicative of ischemia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9415851     DOI: 10.1023/a:1005878705243

Source DB:  PubMed          Journal:  Int J Card Imaging        ISSN: 0167-9899


  7 in total

1.  Accuracy of dobutamine stress echocardiography in detecting coronary artery disease.

Authors:  P A Marcovitz; W F Armstrong
Journal:  Am J Cardiol       Date:  1992-05-15       Impact factor: 2.778

2.  Comparison of the diagnostic potential of four echocardiographic stress tests shortly after acute myocardial infarction: submaximal exercise, transesophageal atrial pacing, dipyridamole, and dobutamine-atropine.

Authors:  K Schröder; H Völler; H Dingerkus; H Münzberg; R Dissmann; T Linderer; H P Schultheiss
Journal:  Am J Cardiol       Date:  1996-05-01       Impact factor: 2.778

3.  Dobutamine stress echocardiography for detection and assessment of coronary artery disease.

Authors:  P K Mazeika; A Nadazdin; C M Oakley
Journal:  J Am Coll Cardiol       Date:  1992-05       Impact factor: 24.094

4.  Dobutamine digital echocardiography for detecting coronary artery disease.

Authors:  J L Cohen; T O Greene; J Ottenweller; S Z Binenbaum; S D Wilchfort; C S Kim
Journal:  Am J Cardiol       Date:  1991-06-15       Impact factor: 2.778

5.  Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography.

Authors:  A J McNeill; P M Fioretti; S M el-Said; A Salustri; T Forster; J R Roelandt
Journal:  Am J Cardiol       Date:  1992-07-01       Impact factor: 2.778

6.  Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease.

Authors:  D Poldermans; P M Fioretti; E Boersma; T Forster; H van Urk; J H Cornel; M Arnese; R T Roelandt
Journal:  Am J Cardiol       Date:  1994-03-01       Impact factor: 2.778

7.  Selection of the optimal nonexercise stress for the evaluation of ischemic regional myocardial dysfunction and malperfusion. Comparison of dobutamine and adenosine using echocardiography and 99mTc-MIBI single photon emission computed tomography.

Authors:  T Marwick; B Willemart; A M D'Hondt; T Baudhuin; W Wijns; J M Detry; J Melin
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.